Frontiers in Pharmacology (Mar 2021)

An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

  • Stefania Merighi,
  • Tino Emanuele Poloni,
  • Lucia Pelloni,
  • Silvia Pasquini,
  • Katia Varani,
  • Fabrizio Vincenzi,
  • Pier Andrea Borea,
  • Stefania Gessi

DOI
https://doi.org/10.3389/fphar.2021.652455
Journal volume & issue
Vol. 12

Abstract

Read online

No abstracts available.

Keywords